- Home
- Publications
- Publication Search
- Publication Details
Title
GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects
Authors
Keywords
-
Journal
Frontiers in Endocrinology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-08-23
DOI
10.3389/fendo.2021.721135
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Polycystic ovary syndrome: a contemporary clinical approach
- (2021) Jelica Bjekić-Macut et al. CURRENT PHARMACEUTICAL DESIGN
- Beinaglutide shows significantly beneficial effects in diabetes/obesity-induced nonalcoholic steatohepatitis in ob/ob mouse model
- (2021) Xiankang Fang et al. LIFE SCIENCES
- The potential role of incretin-based therapies for polycystic ovary syndrome: a narrative review of the current evidence
- (2021) Mohammed Altigani Abdalla et al. Therapeutic Advances in Endocrinology and Metabolism
- Increased co-expression of PSMA2 and GLP-1 receptor in cervical cancer models in type 2 diabetes attenuated by Exendin-4: A translational case-control study
- (2021) Dandan Mao et al. EBioMedicine
- Clinical Effectiveness and Safety of Once-Weekly GLP-1 Receptor Agonist Dulaglutide as Add-On to Metformin or Metformin Plus Insulin Secretagogues in Obesity and Type 2 Diabetes
- (2021) Maria Mirabelli et al. Journal of Clinical Medicine
- Peptidyl and Non-Peptidyl Oral Glucagon-Like Peptide-1 Receptor Agonists
- (2021) Hun Jee Choe et al. Endocrinology and Metabolism
- Effective oral delivery of Exenatide-Zn2+ complex through distal ileum-targeted double layers nanocarriers modified with deoxycholic acid and glycocholic acid in diabetes therapy
- (2021) Ying Han et al. BIOMATERIALS
- Lessons from bariatric surgery: Can increased GLP-1 enhance vascular repair during cardiometabolic-based chronic disease?
- (2021) Ehab Bakbak et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- An Overview of Similarities and Differences in Metabolic Actions and Effects of Central Nervous System Between Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) and Sodium Glucose Co-Transporter-2 Inhibitors (SGLT-2is)
- (2021) Song Wen et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Semaglutide (SUSTAIN and PIONEER) reduces cardiovascular events in type 2 diabetes across varying cardiovascular risk
- (2020) Mansoor Husain et al. DIABETES OBESITY & METABOLISM
- Diagnosis and Treatment of Parkinson Disease
- (2020) Melissa J. Armstrong et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Exendin‐4 enhances the sensitivity of prostate cancer to enzalutamide by targeting Akt activation
- (2020) He Wenjing et al. PROSTATE
- The effect of dulaglutide on stroke: an exploratory analysis of the REWIND trial
- (2020) Hertzel C Gerstein et al. Lancet Diabetes & Endocrinology
- Effects of Novel Dual GIP and GLP-1 Receptor Agonist Tirzepatide on Biomarkers of Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes
- (2020) Mark L. Hartman et al. DIABETES CARE
- A second generation GLP ‐1 receptor agonist mitigates vomiting and anorexia while retaining glucoregulatory potency in lean diabetic and emetic mammalian models
- (2020) Tito Borner et al. DIABETES OBESITY & METABOLISM
- The limits and challenges of antiobesity pharmacotherapy
- (2020) Kishore M Gadde et al. EXPERT OPINION ON PHARMACOTHERAPY
- Obesity, polycystic ovary syndrome and infertility: a new avenue for GLP-1 receptor agonists
- (2020) Hellas Cena et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Evidence summaries and recommendations from the international evidence‐based guideline for the assessment and management of polycystic ovary syndrome: Lifestyle management
- (2020) Lisa J. Moran et al. Obesity Reviews
- Liraglutide: New Perspectives for the Treatment of Polycystic Ovary Syndrome
- (2020) Georgios S. Papaetis et al. CLINICAL DRUG INVESTIGATION
- Effects of glucagon‐like peptide‐1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across body mass index categories in type 2 diabetes: results of the LEADER and SUSTAIN 6 trials
- (2020) Subodh Verma et al. DIABETES OBESITY & METABOLISM
- Synergistic anti-tumor effects of Liraglutide, a glucagon-like peptide-1 receptor agonist, along with Docetaxel on LNCaP prostate cancer cell line
- (2020) Samane Eftekhari et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Parkinson’s disease: etiopathogenesis and treatment
- (2020) Joseph Jankovic et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- The revised International Association for the Study of Pain definition of pain
- (2020) Srinivasa N. Raja et al. PAIN
- The GLP-1R agonist liraglutide limits hepatic lipotoxicity and inflammatory response in mice fed a methionine-choline deficient diet
- (2020) Emmanuel Somm et al. Translational Research
- GLP-1/GLP-1R Signaling Regulates Ovarian PCOS-Associated Granulosa Cells Proliferation and Antiapoptosis by Modification of Forkhead Box Protein O1 Phosphorylation Sites
- (2020) Zhihua Sun et al. International Journal of Endocrinology
- Inflammation in Parkinson’s Disease: Mechanisms and Therapeutic Implications
- (2020) Marta Pajares et al. Cells
- Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective
- (2020) Samik Bindu et al. BIOCHEMICAL PHARMACOLOGY
- Diabetes medications and risk of Parkinson’s disease: a cohort study of patients with diabetes
- (2020) Ruth Brauer et al. BRAIN
- GLP-1 receptor agonists in the treatment of type 2 diabetes: role and clinical experience to date
- (2020) Stephen A. Brunton et al. POSTGRADUATE MEDICINE
- GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art
- (2020) Michael A. Nauck et al. Molecular Metabolism
- Liraglutide and Insulin Have Contrary Effects on Adipogenesis of Human Adipose-Derived Stem Cells via Wnt Pathway
- (2020) Hong Liu et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- The effect of semaglutide 2.4 mg once weekly on energy intake, appetite, control of eating, and gastric emptying in adults with obesity
- (2020) Martin Friedrichsen et al. DIABETES OBESITY & METABOLISM
- Do GLP-1 Receptor Agonists Increase the Risk of Breast Cancer? A Systematic Review and Meta-analysis
- (2020) Giovana F Piccoli et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Liraglutide mends cognitive impairment by averting Notch signaling pathway overexpression in a rat model of polycystic ovary syndrome
- (2020) Muhammed A. Saad et al. LIFE SCIENCES
- Liraglutide Alleviates Hepatic Steatosis by Activating the TFEB-Regulated Autophagy-Lysosomal Pathway
- (2020) Yunyun Fang et al. Frontiers in Cell and Developmental Biology
- Long non-coding RNA lnc-CCNL1-3:1 promotes granulosa cell apoptosis and suppresses glucose uptake in women with polycystic ovary syndrome
- (2020) Jiayu Huang et al. Molecular Therapy-Nucleic Acids
- A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis
- (2020) Philip N. Newsome et al. NEW ENGLAND JOURNAL OF MEDICINE
- Semaglutide is Neuroprotective and Reduces α-Synuclein Levels in the Chronic MPTP Mouse Model of Parkinson’s Disease
- (2019) Liping Zhang et al. Journal of Parkinsons Disease
- The Future of the GLP-1 Receptor Agonists
- (2019) Irl B. Hirsch JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Liraglutide and its Neuroprotective Properties—Focus on Possible Biochemical Mechanisms in Alzheimer’s Disease and Cerebral Ischemic Events
- (2019) Michał Wiciński et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Implications of the local haemodynamic forces on the phenotype of coronary plaques
- (2019) Christos V Bourantas et al. HEART
- Dulaglutide ameliorates STZ induced AD-like impairment of learning and memory ability by modulating hyperphosphorylation of tau and NFs through GSK3β
- (2019) Mei Zhou et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The GLP1 Receptor Agonist Liraglutide Protects Against Oxidized LDL‐Induced Endothelial Inflammation and Dysfunction via KLF2
- (2019) Wen Yue et al. IUBMB LIFE
- Past, present and future perspectives in nonalcoholic fatty liver disease
- (2019) Arun J. Sanyal Nature Reviews Gastroenterology & Hepatology
- The Discovery and Development of Liraglutide and Semaglutide
- (2019) Lotte Bjerre Knudsen et al. Frontiers in Endocrinology
- Once-Weekly Efpeglenatide Dose-Range Effects on Glycemic Control and Body Weight in Patients With Type 2 Diabetes on Metformin or Drug Naive, Referenced to Liraglutide
- (2019) Julio Rosenstock et al. DIABETES CARE
- Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2019) Mansoor Husain et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mechanisms by which GLP-1 receptor agonists and SGLT-2 inhibitors reduce cardiovascular risk
- (2019) Abhinav Sharma et al. Canadian Journal of Diabetes
- Neuroprotection in Rats Following Ischaemia-Reperfusion Injury by GLP-1 Analogues—Liraglutide and Semaglutide
- (2019) Maryna V. Basalay et al. CARDIOVASCULAR DRUGS AND THERAPY
- Polycystic ovarian syndrome: Correlation between hyperandrogenism, insulin resistance and obesity
- (2019) Xin Zeng et al. CLINICA CHIMICA ACTA
- Effect of semaglutide on coronary atherosclerosis progression in patients with type II diabetes
- (2019) Sajad Hamal et al. CORONARY ARTERY DISEASE
- GLP-1 Analog Modulates Appetite, Taste Preference, Gut Hormones and Regional Body Fat Stores in Adults with Obesity
- (2019) Hoda Kadouh et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Metabolic Cytokines at Fasting and During Macronutrient Challenges: Influence of Obesity, Female Androgen Excess and Sex
- (2019) M. Ángeles Martínez-García et al. Nutrients
- Glucagon-Like Peptide-1: A Focus on Neurodegenerative Diseases
- (2019) Maddalena Grieco et al. Frontiers in Neuroscience
- Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
- (2019) Søren L Kristensen et al. Lancet Diabetes & Endocrinology
- Endothelial GLP-1 (Glucagon-Like Peptide-1) Receptor Mediates Cardiovascular Protection by Liraglutide In Mice With Experimental Arterial Hypertension
- (2019) Johanna Helmstädter et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Cardiovascular effects of glucagon-like peptide 1 receptor agonists: from mechanistic studies in humans to clinical outcomes
- (2019) Valerie D Heuvelman et al. CARDIOVASCULAR RESEARCH
- Activation of GLP-1 receptor enhances the chemosensitivity of pancreatic cancer cells
- (2019) He-jun Zhao et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Glucagon-like peptide-1 receptor agonist dulaglutide prevents ox-LDL-induced adhesion of monocytes to human endothelial cells: An implication in the treatment of atherosclerosis
- (2019) Wei Chang et al. MOLECULAR IMMUNOLOGY
- Protective Effects of Incretin Against Age-Related Diseases
- (2019) Di Zhang et al. Current Drug Delivery
- GLP-1 receptor agonists and reduction of cardiometabolic risk: Potential underlying mechanisms
- (2018) Manfredi Rizzo et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Expression of the glucagon-like peptide-1 receptor and its role in regulating autophagy in endometrial cancer
- (2018) Ranka Kanda et al. BMC CANCER
- Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1
- (2018) Daniel J. Drucker Cell Metabolism
- Targeting glucose-dependent insulinotropic polypeptide receptor for neurodegenerative disorders
- (2018) Mahip K. Verma et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Evaluation of different ranges of LH:FSH ratios in polycystic ovarian syndrome (PCOS) – Clinical based case control study
- (2018) N.A. Malini et al. GENERAL AND COMPARATIVE ENDOCRINOLOGY
- Both classic Gs-cAMP/PKA/CREB and alternative Gs-cAMP/PKA/p38β/CREB signal pathways mediate exenatide-stimulated expression of M2 microglial markers
- (2018) Hai-Yun Wu et al. JOURNAL OF NEUROIMMUNOLOGY
- Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment
- (2018) Héctor F. Escobar-Morreale Nature Reviews Endocrinology
- Neuroprotective effects of the novel GLP-1 long acting analogue semaglutide in the MPTP Parkinson's disease mouse model
- (2018) Liping Zhang et al. NEUROPEPTIDES
- Glucagon-like receptor 1 agonists and DPP-4 inhibitors: Anti-diabetic drugs with anti-stroke potential
- (2018) Vladimer Darsalia et al. NEUROPHARMACOLOGY
- Novel dual GLP-1/GIP receptor agonists show neuroprotective effects in Alzheimer's and Parkinson's disease models
- (2018) Christian Hölscher NEUROPHARMACOLOGY
- Hypertension
- (2018) Suzanne Oparil et al. Nature Reviews Disease Primers
- Exendin-4 inhibits glioma cell migration, invasion and epithelial-to-mesenchymal transition through GLP-1R/sirt3 pathway
- (2018) Zhi-Jun Nie et al. BIOMEDICINE & PHARMACOTHERAPY
- Recent updates on GLP-1 agonists: Current advancements & challenges
- (2018) Dilip Sharma et al. BIOMEDICINE & PHARMACOTHERAPY
- Alzheimer's Disease: Recent Advances and Future Perspectives
- (2018) Kiren Ubhi et al. JOURNAL OF ALZHEIMERS DISEASE
- The amyloid hypothesis on trial
- (2018) Simon Makin NATURE
- Glucagon-like peptide-1 receptor action in the vasculature
- (2018) Malak Almutairi et al. PEPTIDES
- Epidemiology of cardiovascular disease in China: current features and implications
- (2018) Dong Zhao et al. Nature Reviews Cardiology
- Exendin-4, a Glucagonlike Peptide-1 Receptor Agonist, Attenuates Breast Cancer Growth by Inhibiting NF-κB Activation
- (2017) Chikayo Iwaya et al. ENDOCRINOLOGY
- SIRT1/HSF1/HSP pathway is essential for exenatide-alleviated, lipid-induced hepatic endoplasmic reticulum stress
- (2017) Xiaobin Zheng et al. HEPATOLOGY
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
- (2017) Naga Chalasani et al. HEPATOLOGY
- Effect of acute physiological free fatty acid elevation in the context of hyperinsulinemia on fiber type-specific IMCL accumulation
- (2017) Lisa S. Chow et al. JOURNAL OF APPLIED PHYSIOLOGY
- Glucagon-like peptide-1 analog, liraglutide, improves visceral sensation and gut permeability in rats
- (2017) Tsukasa Nozu et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Autocrine Interleukin-10 Mediates Glucagon-Like Peptide-1 Receptor-Induced Spinal Microglial β-Endorphin Expression
- (2017) Hai-Yun Wu et al. JOURNAL OF NEUROSCIENCE
- The Transition of Acute Postoperative Pain to Chronic Pain: An Integrative Overview of Research on Mechanisms
- (2017) C. Richard Chapman et al. JOURNAL OF PAIN
- Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial
- (2017) Dilan Athauda et al. LANCET
- Stroke
- (2017) Graeme J Hankey LANCET
- p38 β Mitogen-Activated Protein Kinase Signaling Mediates Exenatide-Stimulated Microglial β -Endorphin Expression
- (2017) Hai-Yun Wu et al. MOLECULAR PHARMACOLOGY
- Animal models of α-synucleinopathy for Parkinson disease drug development
- (2017) James B. Koprich et al. NATURE REVIEWS NEUROSCIENCE
- Glucagon-like Peptide-1 and the Central/Peripheral Nervous System: Crosstalk in Diabetes
- (2017) Giovanna Muscogiuri et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Short-term effectiveness of low dose liraglutide in combination with metformin versus high dose liraglutide alone in treatment of obese PCOS: randomized trial
- (2017) Mojca Jensterle et al. BMC Endocrine Disorders
- GLP-1 receptor agonists in the treatment of polycystic ovary syndrome
- (2017) Elizabeth Mary Lamos et al. Expert Review of Clinical Pharmacology
- Parkinson disease
- (2017) Werner Poewe et al. Nature Reviews Disease Primers
- Exenatide modulates tumor–endothelial cell interactions in human ovarian cancer cells
- (2017) Agnieszka Kosowska et al. Endocrine Connections
- GLP-1 Receptor Stimulation Reduces Amyloid-β Peptide Accumulation and Cytotoxicity in Cellular and Animal Models of Alzheimer's Disease
- (2017) Yazhou Li et al. JOURNAL OF ALZHEIMERS DISEASE
- Resveratrol and caloric restriction prevent hepatic steatosis by regulating SIRT1-autophagy pathway and alleviating endoplasmic reticulum stress in high-fat diet-fed rats
- (2017) Shibin Ding et al. PLoS One
- Neuroinflammation in Alzheimer's disease: Current evidence and future directions
- (2016) Valeria Calsolaro et al. Alzheimers & Dementia
- Role of glucagon-like peptide 1 receptor agonists in management of obesity
- (2016) D. Isaacs et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- GLP-1 analogue improves hepatic lipid accumulation by inducing autophagy via AMPK/mTOR pathway
- (2016) Qin He et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- MicroRNA-183-96-182 Cluster Regulates Bovine Granulosa Cell Proliferation and Cell Cycle Transition by Coordinately Targeting FOXO11
- (2016) Samuel Gebremedhn et al. BIOLOGY OF REPRODUCTION
- Diabetes negatively affects cortical and striatal GABAergic neurons: an effect that is partially counteracted by exendin-4
- (2016) M. Larsson et al. BIOSCIENCE REPORTS
- The Cardiovascular Biology of Glucagon-like Peptide-1
- (2016) Daniel J. Drucker Cell Metabolism
- Use of incretin agents and risk of pancreatic cancer: a population-based cohort study
- (2016) L. M. Knapen et al. DIABETES OBESITY & METABOLISM
- GLP-1 receptor agonist promotes brown remodelling in mouse white adipose tissue through SIRT1
- (2016) Fen Xu et al. DIABETOLOGIA
- The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in Parkinson's disease: mechanisms of action
- (2016) Dilan Athauda et al. DRUG DISCOVERY TODAY
- The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited
- (2016) Robert L. Rosenfield et al. ENDOCRINE REVIEWS
- Leptin-Induced CART (Cocaine- and Amphetamine-Regulated Transcript) Is a Novel Intraovarian Mediator of Obesity-Related Infertility in Females
- (2016) Xiaoting Ma et al. ENDOCRINOLOGY
- Type 2 Diabetes Mellitus and Cancer: The Role of Pharmacotherapy
- (2016) Gadi Shlomai et al. JOURNAL OF CLINICAL ONCOLOGY
- Mitochondrial dysfunction in Parkinson's disease
- (2016) Anindita Bose et al. JOURNAL OF NEUROCHEMISTRY
- Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
- (2016) Mohammad H Forouzanfar et al. LANCET
- Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
- (2016) Matthew James Armstrong et al. LANCET
- Pharmacological management of nonalcoholic fatty liver disease
- (2016) Diana Barb et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Exendin-4 inhibits growth and augments apoptosis of ovarian cancer cells
- (2016) Wenjing He et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neuroprotective effects of glucose-dependent insulinotropic polypeptide in Alzheimer’s disease
- (2016) Chenhui Ji et al. REVIEWS IN THE NEUROSCIENCES
- An overview of treatment approaches for chronic pain management
- (2016) Nicholas Hylands-White et al. RHEUMATOLOGY INTERNATIONAL
- Sex steroid receptors and apoptosis-related proteins are differentially expressed in polycystic ovaries of adult dogs
- (2016) Luiz Gustavo de Almeida Chuffa et al. TISSUE & CELL
- Polycystic ovary syndrome
- (2016) Ricardo Azziz et al. Nature Reviews Disease Primers
- Eight principles for safer opioid prescribing and cautions with benzodiazepines
- (2016) Lynn R. Webster et al. POSTGRADUATE MEDICINE
- The Neuroprotection of Liraglutide Against Ischaemia-induced Apoptosis through the Activation of the PI3K/AKT and MAPK Pathways
- (2016) Huili Zhu et al. Scientific Reports
- Intranasal Delivery of Exendin-4 Confers Neuroprotective Effect Against Cerebral Ischemia in Mice
- (2015) Huinan Zhang et al. AAPS Journal
- Influence of microglial activation on neuronal function in Alzheimer's and Parkinson's disease dementia
- (2015) Zhen Fan et al. Alzheimers & Dementia
- Resveratrol prevents insulin resistance caused by short-term elevation of free fatty acids in vivo
- (2015) Sandra Pereira et al. Applied Physiology Nutrition and Metabolism
- Atherosclerosis
- (2015) Hong Lu et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- The Glucagon-Like Peptide-1 Analogue Liraglutide Inhibits Oxidative Stress and Inflammatory Response in the Liver of Rats with Diet-Induced Non-alcoholic Fatty Liver Disease
- (2015) Huiting Gao et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Liraglutide attenuates high glucose-induced abnormal cell migration, proliferation, and apoptosis of vascular smooth muscle cells by activating the GLP-1 receptor, and inhibiting ERK1/2 and PI3K/Akt signaling pathways
- (2015) Lili Shi et al. Cardiovascular Diabetology
- Neuroprotective effects of geniposide in the MPTP mouse model of Parkinson's disease
- (2015) YiMei Chen et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients
- (2015) Guillaume Lassailly et al. GASTROENTEROLOGY
- Glucagon-Like Receptor 1 Agonists and DPP-4 Inhibitors: Potential Therapies for the Treatment of Stroke
- (2015) Vladimer Darsalia et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Parkinson's disease
- (2015) Lorraine V Kalia et al. LANCET
- Hypertension
- (2015) Neil R Poulter et al. LANCET
- Restoration of Cerebral and Systemic Microvascular Architecture in APP/PS1 Transgenic Mice Following Treatment with Liraglutide™
- (2015) Patricia Kelly et al. MICROCIRCULATION
- Saxagliptin: A novel antiparkinsonian approach
- (2015) Noha N. Nassar et al. NEUROPHARMACOLOGY
- Neuroprotective effects of lixisenatide and liraglutide in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson’s disease
- (2015) W. Liu et al. NEUROSCIENCE
- Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality
- (2015) Gregory A. Roth et al. NEW ENGLAND JOURNAL OF MEDICINE
- Exenatide inhibits the growth of endometrial cancer Ishikawa xenografts in nude mice
- (2015) YU ZHANG et al. ONCOLOGY REPORTS
- Is it a stroke?
- (2015) G. J. Hankey et al. BMJ-British Medical Journal
- Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies
- (2015) K. K. Tsilidis et al. BMJ-British Medical Journal
- Is it a stroke?
- (2015) G. J. Hankey et al. BMJ-British Medical Journal
- Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies
- (2015) K. K. Tsilidis et al. BMJ-British Medical Journal
- Polycystic Ovary Syndrome: Update on Diagnosis and Treatment
- (2014) Tracy L. Setji et al. AMERICAN JOURNAL OF MEDICINE
- Activation of glucagon-like peptide-1 receptor inhibits growth and promotes apoptosis of human pancreatic cancer cells in a cAMP-dependent manner
- (2014) Hejun Zhao et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Insulin, incretins and other growth factors as potential novel treatments for Alzheimer's and Parkinson's diseases
- (2014) Christian Hölscher BIOCHEMICAL SOCIETY TRANSACTIONS
- The non-peptide GLP-1 receptor agonist WB4-24 blocks inflammatory nociception by stimulating β-endorphin release from spinal microglia
- (2014) Hui Fan et al. BRITISH JOURNAL OF PHARMACOLOGY
- Exendin-4, a GLP-1 Receptor Agonist, Attenuates Prostate Cancer Growth
- (2014) Takashi Nomiyama et al. DIABETES
- Cancer Risk Among People With Type 1 and Type 2 Diabetes: Disentangling True Associations, Detection Bias, and Reverse Causation
- (2014) Jessica L. Harding et al. DIABETES CARE
- Activation of glucagon-like peptide-1 receptor inhibits tumourigenicity and metastasis of human pancreatic cancer cells via PI3K/Akt pathway
- (2014) H. Zhao et al. DIABETES OBESITY & METABOLISM
- Liraglutide: A Review of Its Use in Adult Patients with Type 2 Diabetes Mellitus
- (2014) Lesley J. Scott DRUGS
- GLP-1 Receptor Localization in Monkey and Human Tissue: Novel Distribution Revealed With Extensively Validated Monoclonal Antibody
- (2014) Charles Pyke et al. ENDOCRINOLOGY
- Activation of Spinal Glucagon-Like Peptide-1 Receptors Specifically Suppresses Pain Hypersensitivity
- (2014) N. Gong et al. JOURNAL OF NEUROSCIENCE
- Geniposide and its iridoid analogs exhibit antinociception by acting at the spinal GLP-1 receptors
- (2014) Nian Gong et al. NEUROPHARMACOLOGY
- Weight loss effect of glucagon-like peptide-1 mimetics on obese/overweight adults without diabetes: A systematic review and meta-analysis of randomized controlled trials胰高血糖素样肽-1类似物对非糖尿病肥胖/超重成人的减重作用：一篇对随机对照试验进行的系统评价及meta分析
- (2014) Fang Zhang et al. Journal of Diabetes
- The Effect of Liraglutide on Weight Loss in Women with Polycystic Ovary Syndrome: An Observational Study
- (2014) Christina B. Rasmussen et al. Frontiers in Endocrinology
- Pharmacology, Physiology, and Mechanisms of Incretin Hormone Action
- (2013) Jonathan E. Campbell et al. Cell Metabolism
- Blood pressure-lowering effects of GLP-1 receptor agonists exenatide and liraglutide: a meta-analysis of clinical trials
- (2013) B. Wang et al. DIABETES OBESITY & METABOLISM
- The extra-pancreatic effects of GLP-1 receptor agonists: a focus on the cardiovascular, gastrointestinal and central nervous systems
- (2013) J. Seufert et al. DIABETES OBESITY & METABOLISM
- Molecular mechanisms of neuropathological changes in Alzheimer’s disease: a review
- (2013) Omar Šerý et al. FOLIA NEUROPATHOLOGICA
- Neuroprotective Effects of Liraglutide for Stroke Model of Rats
- (2013) Kenichiro Sato et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Exenatide and the treatment of patients with Parkinson’s disease
- (2013) Iciar Aviles-Olmos et al. JOURNAL OF CLINICAL INVESTIGATION
- Central effects of GLP-1: new opportunities for treatments of neurodegenerative diseases
- (2013) Christian Hölscher JOURNAL OF ENDOCRINOLOGY
- GLP-1 analogue prevents NAFLD in ApoE KO mice with diet and Acrp30 knockdown by inhibiting c-JNK
- (2013) Lili Zhang et al. LIVER INTERNATIONAL
- GLP-1 receptor activation and Epac2 link atrial natriuretic peptide secretion to control of blood pressure
- (2013) Minsuk Kim et al. NATURE MEDICINE
- Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease
- (2013) Paula L. McClean et al. NEUROPHARMACOLOGY
- GLP-1R agonist therapy for diabetes
- (2013) Susan L. Samson et al. Current Opinion in Endocrinology Diabetes and Obesity
- Glucagonlike Peptide 1–Based Therapies and Risk of Hospitalization for Acute Pancreatitis in Type 2 Diabetes Mellitus
- (2013) Sonal Singh et al. JAMA Internal Medicine
- Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance
- (2012) Karthika Natarajan et al. BIOCHEMICAL PHARMACOLOGY
- Neuroprotective and neurotrophic actions of glucagon-like peptide-1: an emerging opportunity to treat neurodegenerative and cerebrovascular disorders
- (2012) Isidro Salcedo et al. BRITISH JOURNAL OF PHARMACOLOGY
- A meta-analysis of serious adverse events reported with exenatide and liraglutide: Acute pancreatitis and cancer
- (2012) Carlos Alves et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer’s disease–associated Aβ oligomers
- (2012) Theresa R. Bomfim et al. JOURNAL OF CLINICAL INVESTIGATION
- GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus
- (2012) Juris J. Meier Nature Reviews Endocrinology
- Liraglutide protects against amyloid-β protein-induced impairment of spatial learning and memory in rats
- (2012) Wei-Na Han et al. NEUROBIOLOGY OF AGING
- Glucagon-like peptide-1 activates endothelial nitric oxide synthase in human umbilical vein endothelial cells
- (2011) Li Ding et al. ACTA PHARMACOLOGICA SINICA
- Exendin-4, a glucagon-like peptide-1 receptor agonist, reduces intimal thickening after vascular injury
- (2011) Hiromasa Goto et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- A GLP-1 receptor agonist liraglutide inhibits endothelial cell dysfunction and vascular adhesion molecule expression in an ApoE-/- mouse model
- (2011) Tracey Gaspari et al. Diabetes & Vascular Disease Research
- Exendin-4, a Glucagon-Like Peptide-1 Receptor Agonist, Provides Neuroprotection in Mice Transient Focal Cerebral Ischemia
- (2011) Shinichiro Teramoto et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Glucagon Like Peptide-1 Receptor Expression in the Human Thyroid Gland
- (2011) Belinda Gier et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The Diabetes Drug Liraglutide Prevents Degenerative Processes in a Mouse Model of Alzheimer's Disease
- (2011) P. L. McClean et al. JOURNAL OF NEUROSCIENCE
- Novel GLP-1 mimetics developed to treat type 2 diabetes promote progenitor cell proliferation in the brain
- (2011) A. Hamilton et al. JOURNAL OF NEUROSCIENCE RESEARCH
- GLP-1 playing the role of a gut regulatory compound
- (2010) P. M. Hellström Acta Physiologica
- From the metabolic syndrome to NAFLD or vice versa?
- (2010) Ester Vanni et al. DIGESTIVE AND LIVER DISEASE
- The glucagon-like peptide 1 receptor agonist exendin-4 improves reference memory performance and decreases immobility in the forced swim test
- (2010) Ruben Isacson et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Metabolic features of the reproductive phenotypes of polycystic ovary syndrome
- (2009) Lisa Moran et al. HUMAN REPRODUCTION UPDATE
- Exendin-4 protects dopaminergic neurons by inhibition of microglial activation and matrix metalloproteinase-3 expression in an animal model of Parkinson's disease
- (2009) Sehee Kim et al. JOURNAL OF ENDOCRINOLOGY
- [11C]-PK11195 PET: Quantification of neuroinflammation and a monitor of anti-inflammatory treatment in Parkinson's disease?
- (2009) A.L. Bartels et al. PARKINSONISM & RELATED DISORDERS
- GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism
- (2009) Y. Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cellular neuroadaptations to chronic opioids: tolerance, withdrawal and addiction
- (2008) M J Christie BRITISH JOURNAL OF PHARMACOLOGY
- Comparison of Single and Combined Treatment with Exenatide and Metformin on Menstrual Cyclicity in Overweight Women with Polycystic Ovary Syndrome
- (2008) Karen Elkind-Hirsch et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Obesity, Pancreatitis, and Pancreatic Cancer
- (2008) Andrew A. Gumbs OBESITY SURGERY
- Peptide hormone exendin-4 stimulates subventricular zone neurogenesis in the adult rodent brain and induces recovery in an animal model of parkinson's disease
- (2007) Göran Bertilsson et al. JOURNAL OF NEUROSCIENCE RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now